NCT05976373View on ClinicalTrials.gov

A Study to Investigate the Pharmacokinetics (PK), Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants.

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 5, 2015

Primary Completion Date

March 30, 2015

Study Completion Date

March 30, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

Dupilumab (SAR231893)

injection solution subcutaneous

Trial Locations (1)

55144

Prism Research-Site Number:840001, Saint Paul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY

NCT05976373 - A Study to Investigate the Pharmacokinetics (PK), Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants. | Biotech Hunter | Biotech Hunter